HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

MEOW-1 trial will test a GLP-1 implant in overweight cats

Louis Nervegna · Dec 04, 2025 · ♥ 3 reactions · 1 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)
AI summary & key facts

Louis jokes about a news item that Okava Pharmaceuticals is starting MEOW-1, a trial of a miniature GLP-1 implant delivering drug for up to six months in cats. No human health content.

The MEOW-1 clinical trial is studying GLP-1 agonist drugs in overweight cats. Lol

#glp1HD

Shared from ABC News · original post

A biopharmaceutical company is looking for ways to slim down household pets.

Okava Pharmaceuticals, a San Francisco based company, is introducing a new GLP-1 clinical weight loss study for cats.

MEOW-1, as the study is called, will look to use a miniature implant in cats which will deliver the GLP-1 continuously for up to six months.

According to Okava, MEOW-1 is the first-ever weight loss trial using this approach on household pets.

Read more:

ABC NewsWeight loss drugs for cats? Company launches clinical trial of GLP-1 implants in catsThe new implants will be for weight loss in cats and dogsabcnews.comNo photo description available.
#weightloss
← newer: A 50:50 salt/potassium blend cuts sodium and adds potassium;older: Why some people with very high Lp(a) have clean arteries: ox →